269 related articles for article (PubMed ID: 11695647)
1. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
2. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues.
Mattern RH; Tran TA; Goodman M
J Pept Sci; 1999 Apr; 5(4):161-75. PubMed ID: 10323196
[TBL] [Abstract][Full Text] [Related]
3. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate.
Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR
Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
[TBL] [Abstract][Full Text] [Related]
7. A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
Ulysse LG; Chmielewski J
Chem Biol Drug Des; 2006 Feb; 67(2):127-36. PubMed ID: 16492160
[TBL] [Abstract][Full Text] [Related]
8. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
9. Peptide conformation. 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin.
Kessler H; Klein M; Wagner K
Int J Pept Protein Res; 1988 May; 31(5):481-98. PubMed ID: 2900820
[TBL] [Abstract][Full Text] [Related]
10. Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8.
Mattern RH; Zhang L; Rueter JK; Goodman M
Biopolymers; 2000 May; 53(6):506-22. PubMed ID: 10775066
[TBL] [Abstract][Full Text] [Related]
11. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
12. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues.
Mattern RH; Tran TA; Goodman M
J Med Chem; 1998 Jul; 41(15):2686-92. PubMed ID: 9667959
[TBL] [Abstract][Full Text] [Related]
13. Structural model of a cyclic dynorphin A analog bound to dodecylphosphocholine micelles by NMR and restrained molecular dynamics.
Tessmer MR; Meyer JP; Hruby VJ; Kallick DA
J Med Chem; 1997 Jul; 40(14):2148-55. PubMed ID: 9216833
[TBL] [Abstract][Full Text] [Related]
14. Bioactive peptides: solid state, solution and molecular dynamics studies of a cyclolinopeptide A-related cystinyl cyclopentapeptide.
Rossi F; Saviano M; Di Blasio B; Zanotti G; Maione AM; Tancredi T; Pedone C
Biopolymers; 1994 Feb; 34(2):273-84. PubMed ID: 8142593
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
16. A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.
Gilon C; Huenges M; Mathä B; Gellerman G; Hornik V; Afargan M; Amitay O; Ziv O; Feller E; Gamliel A; Shohat D; Wanger M; Arad O; Kessler H
J Med Chem; 1998 Mar; 41(6):919-29. PubMed ID: 9526566
[TBL] [Abstract][Full Text] [Related]
17. Conformational analyses by 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues.
Mattern RH; Tran TA; Goodman M
J Pept Res; 1999 Feb; 53(2):146-60. PubMed ID: 10195452
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the active conformation of urotensin II.
Carotenuto A; Grieco P; Campiglia P; Novellino E; Rovero P
J Med Chem; 2004 Mar; 47(7):1652-61. PubMed ID: 15027856
[TBL] [Abstract][Full Text] [Related]
19. The pseudo-beta I-turn. A new structural motif with a cis peptide bond in cyclic hexapeptides.
Kessler H; Matter H; Gemmecker G; Diehl HJ; Isernia C; Mronga S
Int J Pept Protein Res; 1994 Jan; 43(1):47-61. PubMed ID: 8138351
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a novel cis-proline-derived cyclic type VI beta-turn mimic via ring-closing metathesis.
Boruah A; Rao IN; Nandy JP; Kumar SK; Kunwar AC; Iqbal J
J Org Chem; 2003 Jun; 68(12):5006-8. PubMed ID: 12790624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
